Condition
HPV Vaccine Acceptability
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed2
Not Yet Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04945655Not ApplicableCompletedPrimary
Impact of a School- and Primary Care-based Multicomponent Intervention on HPV Vaccination Acceptability
NCT06683664Not ApplicableNot Yet Recruiting
HPV Vaccine Integrated Service Implementation Research in Cameroon
NCT06667323Not ApplicableNot Yet Recruiting
HPV Vaccine Integrated Service Implementation Research in Ethiopia
NCT01431079Phase 4CompletedPrimary
A Health Belief Model Based Intervention to Increase Human Papilloma Virus (HPV) Vaccination Among College Men
Showing all 4 trials